J Crohns Colitis. 2019 Dec 26. [Epub ahead of print]

Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Infammatory Bowel Diseases

Michaël Somers, Peter Bossuyt, Marc Ferrante, Harald Peeters, Filip Baert ; for BIRD [Belgian IBD Research and Development]

Read abstract
Visit website

THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 94, No. 8, 1999 - 1999 by Am. Coll. of Gastroenterology ISSN 0002-9270/99/$20.00 Published by Elsevier Science Inc.

Acute Lower Gastrointestinal Bleeding in Crohn's Disease: Characteristics of a Unique Series of 34 Patients

Jacques Belaiche, M.D., Edouard Louis, M.D., Geert D'Haens, M.D., Marc Cabooter, M.D., Serge Naegels, M.D., Martine De Vos, M.D., Fernand Fontaine, M.D., Piet Schurmans, M.D., Filip Baert, M.D., Marc De Reuck, M.D., René Fiasse, M.D., Jan Holvoet, M.D., Alain Schmit, M.D., Marc Van Outryve, M.D., and the Belgian IBD Research Group

Read abstract

Gastroenterology 2002; 122:20-25

Budesonide in Collagenous Colitis: A Double-Blind Placebo-Controlled Trial With Histologic Follow-Up FILIP

Filip Baert, Alain Schmit, Geert D'haens, Franceska Dedeurwaerdere, Edouard Louis, Marc Cabooter, Martine De Vos, Fernand Fontaine, Serge Naegels, Piet Schurmans, Hedwig Stals, Karel Geboes, And Paul Rutgeerts, for the Belgian Ibd Research Group and Codali Brussels, Belgium.

Read abstract

Journal of Crohn's and Colitis (2007) 1, 21-27

Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis

N. Eleftheriadis, G. Lambrecht, G. D'Haens, F. Baert, M. Cabooter, E. Louis, G. Van Assche, P. Schurmans, P. Caenepeel, M. Van Outryve, P. Lammens, A. Van Gossum, M. De Vos on behalf of the Belgian IBD Research Group

Read abstract

Acta Gastro-Enterologica Belgica, Vol. LXX, April-June 2007

Immunogenicity of infliximab: how to handle the problem?

Filip Baert, Martine De Vos, Edouard Louis and Séverine Vermeire for the Belgian IBD Research Group

Read abstract

The lancet - Vol 371 February 23, 2008

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D'Haens, Filip Baert, Gert van Assche, Philip Caenepeel, Philippe Vergauwe, Hans Tuynman, Martine De Vos, Sander van Deventer, Larry Stitt, Allan Donner, Severine Vermeire, Frank J Van De Mierop, Jean-Charles R Coche, Janneke van der Woude, Thomas Ochsenkühn, Ad A van Bodegraven, Philippe P Van Hootegem, Guy L Lambrecht, Fazia Mana, Paul Rutgeerts, Brian G Feagan, Daniel Hommes, for the Belgian Infl ammatory Bowel Disease Research Group and the North-Holland Gut Club

Read abstract

Gastroenterology 2010; 138:463-468

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Filip Baert, Liesbeth Moortgat, Gert Van Assche, Philip Caenepeel, Philippe Vergauwe,Martine De Vos, Pieter Stokkers, Daniel Hommes, Paul Rutgeerts, Severine Vermeire and Geert D'haens for the Belgian Inflammatory Bowel Disease Research Group and The North-Holland Gut Club

Read abstract

Inflamm Bowel Dis - Volume 16, Number 2, February 2010

Efficacy of Infliximab in Refractory Pouchitis and Crohn's Disease-Related Complications of the Pouch: A Belgian Case Series

Marc Ferrante, Geert D'Haens, Olivier Dewit, Filip Baert, Jan Holvoet, Karel Geboes, Gert De Hertogh, Gert Van Assche, Séverine Vermeire, and Paul Rutgeerts, on behalf of the Belgian IBD Research Group.

Read abstract

Clinical Biochemistry 44 (2011) 1062-1066

Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients

O. Dewit, T. Moreels, F. Baert, H. Peeters, C. Reenaers, M. de Vos, Ph. Van Hootegem, V. Muls, G. Veereman, F. Mana, M. Van Outryve, J. Holvoet, S. Naegels, H. Piessevaux, Y. Horsmans, J.L. Gala on behalf of the Belgian Inflammatory Bowel Disease Research Group (BIRD)

Read abstract

Journal of Crohn's and Colitis (2012) 6, 557-562

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

M. De Vos, O. Dewit, G. D'Haens, F. Baert, F. Fontaine, S. Vermeire, D. Franchimont, T. Moreels, D. Staessen, L. Terriere, B. Vander Cruyssen, E. Louis on behalf of BIRD

Read abstract

Journal of Crohn's and Colitis (2013) 7, e588-e598

Profile of pediatric Crohn's disease in Belgium

E. De Greef, J.M. Mahachie John, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot, P. Alliet, W. Arts, O. Dewit, H. Peeters, F. Baert, G. D'Haens, J.F. Rahier, I. Etienne, O. Bauraind, A. Van Gossum, S. Vermeire, F. Fontaine, V. Muls, E. Louis, F. Van de Mierop, J.C. Coche, K. Van Steen, G. Veereman for the IBD working group of the Belgian Society of Pediatric Gastroenterology, Hepatology and Nutrition (BeSPGHAN) and the Belgian IBD Research and Development (BIRD)

Read abstract

Journal of Crohn's and Colitis (2013) 7, 154-160

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn\'s patients

Filip Baert, Elien Glorieus, Cathérine Reenaers, Geert D'Haens, Harald Peeters, Dennis Franchimont, Olivier Dewit, Philippe Caenepeel, Edouard Louis, Gert Van Assche for BIRD (Belgian IBD Research and Development)

Read abstract

Inflamm Bowel Dis - Volume 19, Number 10, September 2013

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

Martine De Vos, Edouard J. Louis, Jürgen Jahnsen, Jo G.P. Vandervoort, Maja Noman, Olivier Dewit, Geert R. D'Haens, Denis Franchimont, Filip J. Baert, Roald A. Torp, Magne Henriksen, Philippe M.R. Potvin, Philippe P. Van Hootegem, Pieter M. Hindryckx, Tom G. Moreels, Arnaud Collard, Lars Normann Karlsen, Eirik Kittang, Guy Lambrecht, Tore Grimstad, Jonas Koch, Idar Lygren, Jean-Claude R.J. Coche, Fazia Mana, Andre Van Gossum, Jacques Belaiche, Mike R. Cool, Fernand Fontaine, Jean-Marc G. Maisin, Vinciane Muls, Bart Neuville, Dirk A. J. Staessen, Gert A. Van Assche, Thomas de Lange, Inger Camilla Solberg, Bert J.K. Vander Cruyssen, and Severine A.R.A. Vermeire

Read abstract

United European Gastroenterol J. 2018 Apr;6(3):439-445

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

De Vos M1, Dhooghe B1, Vermeire S2, Louis E3, Mana F4, Elewaut A5, Bossuyt P6, Baert F7, Reenaers C3, Van Gossum M8, Macken E9, Ferrante M2, Hindryckx P1, Dewit O10, Holvoet T1, Franchimont D8; Belgian Inflammatory Bowel Disease Research and Development (BIRD)

Read abstract
Visit website

United European Gastroenterology Journal, First Published 20 Jun 2018.

Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

C. Reenaers, P. Bossuyt, P. Hindryckx, H. Vanpoucke, A. Cremer, F. Baert; Belgian IBD Research and Development Group

Read abstract
Visit website

Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):49-53.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

D. Franchimont, M. Ferrante, E. Louis, M. De Vos, O. Dewit, P. Van Hootegem, T. Moreels, C. Liefferinckx, P. Bossuyt, F. Baert, JF. Rahier, S. Vermeire ; Belgian IBD Research and Development Group

Read abstract
Visit website

Inflamm Bowel Dis. 2018 Jun 15. doi: 10.1093/ibd/izy219. [Epub ahead of print]

Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.

P.Bossuyt, F.Baert, F.D'Heygere, A.Nakad, C.Reenaers, F.Fontaine, D.Franchimont, O.Dewit, P.Van Hootegem, S.VandenBranden, G.Lambrecht, M.Ferrante; Belgian IBD Research and Development Group

Read abstract
Visit website

Inflamm Bowel Dis. 2018 Apr 23;24(5):1099-1105

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Van de Vondel S, Baert F, Reenaers C, Vanden Branden S, Amininejad L, Dewint P, Van Moerkercke W, Rahier JF, Hindryckx P, Bossuyt P, Ferrante M; Belgian IBD Research and Development (BIRD)

Read abstract
Visit website